AXISCADES Technologies Limited (AXISCADES)
Q1 FY27 - Results Presentation
Press Release - Q1 FY27
- Record consolidated revenue Rs 346.7 Cr +42.2% y-y; retained revenue Rs 183.4 Cr +94.2% y-y
- Defence revenue +111% y-y at Rs 125 Cr; 75% y-y growth guidance for FY27
- XiDA platform revenue Rs 49.5 Cr +62% y-y; expects 100%+ growth from FY27
- Aerospace manufacturing ramping with Rs 6.1 Cr revenue; acquisition to add Rs 180 Cr revenue annualised
- Divestment of engineering services for $237 Mn closing by Nov 2026; Rs 1,255 Cr extraordinary gain expected
- Normalised EBITDA Rs 41 Cr at 11.8% margin; Add Solutions remains loss-making
- Space division launched; partnerships to be announced Sep 2026
- Capital allocation focused on aerospace, defence, XiDA, spacetech; no equity dilution
- Assured forecast visibility Rs 4,557 Cr including Rs 332 Cr new defence wins
- CAM facility land allocation in process; quad-use manufacturing hub by Q4 FY27
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 AXISCADES — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add AXISCADES to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on AXISCADES Technologies Limited
Important.
The summary above is generated automatically from AXISCADES Technologies Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.